4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Universe Pharmaceuticals INC (UPC) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ji'An, China with about 216 employees. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-09-30, UPC reported $18M in revenue and ($4M) in net income.
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
Interactive charts & full statements → Open the UPC valuation workbench →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $18M | $23M | $32M | $40M | — |
| Gross Profit | $6M | $6M | $10M | $22M | — |
| Operating Income (EBIT) | ($3M) | ($8M) | ($4M) | ($7M) | — |
| Net Income | ($4M) | ($9M) | ($7M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $69M | $68M | $42M | $60M | — |
| Total Liabilities | $13M | $22M | $14M | $13M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UPC viewer.
About TickerBase · Data methodology & sources